What sector does ImmunoPrecise Antibodies Ltd. (HYFT) operate in?
ImmunoPrecise Antibodies Ltd. belongs to the Information Technology sector and operates in the Biotechnology industry.
What is ImmunoPrecise Antibodies Ltd. (HYFT) current stock price?
As of the latest data, ImmunoPrecise Antibodies Ltd. stock price is $1.18, with a previous close of $1.09. ImmunoPrecise Antibodies Ltd. gained $0.09 in the last trading session, representing a 8.26% increase.
What is ImmunoPrecise Antibodies Ltd. (HYFT) current market capitalization?
ImmunoPrecise Antibodies Ltd. market cap is approximately 55.12 million.
What is ImmunoPrecise Antibodies Ltd. (HYFT) Earnings Per Share (EPS)?
The trailing EPS is -$0.10, and the forward EPS is -$0.17.
What is ImmunoPrecise Antibodies Ltd. (HYFT) EBITDA?
ImmunoPrecise Antibodies Ltd. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.50 million.
Does ImmunoPrecise Antibodies Ltd. (HYFT) pay dividends?
No. ImmunoPrecise Antibodies Ltd. does not pay a dividend.
How did ImmunoPrecise Antibodies Ltd. (HYFT) perform in its most recent earnings report?
In the last report (January 31, 2026), ImmunoPrecise Antibodies Ltd. posted an EPS surprise of -63.33% and a revenue surprise of -34.81%.
What is ImmunoPrecise Antibodies Ltd. (HYFT) beta (volatility) score?
ImmunoPrecise Antibodies Ltd. has a beta of 0.669, indicating lower volatility than the overall market.